FOR IMMEDIATE RELEASE Empire Genomics, a Biocare Medical Company, Partners with BioDot to Launch First Pre-Optimized Hematology FISH Probe Panels and Controls for the CellWriter™ S Platform New BDot Probe Panels Streamline and Accelerate FISH Testing for Hematologic Malignancies with Exceptional Performance and Compatibility Buffalo, NY and Irvine, CA – April 24, 2025 — Empire […]
Category Archives: News
Dear Valued Customer, At Empire Genomics, we are committed to maintaining transparency and delivering the highest level of service to our customers. We want to inform you that we are currently evaluating the potential impact of recently announced tariffs on our supply chain and manufacturing processes. While we strive to manufacture the vast majority of […]
Important Regulatory Update: On March 31, 2025, the U.S. District Court for the Eastern District of Texas vacated the FDA’s Final Rule concerning Laboratory Developed Tests (LDTs). This decision effectively removes FDA-imposed restrictions and reaffirms the oversight of LDTs under CLIA regulations managed by CMS. What does this mean for your lab? Continuing Use of […]
Buffalo, New York – April 1, 2024 – Empire Genomics Corp has been awarded a national group purchasing agreement for Molecular Analyzers, Reagents with Premier, Inc. Effective 02/01/2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for FISH (Fluorescent in situ Hybridization) Probes.“Empire Genomics […]